Yahoo Finance Gossamer Bio Decline Means Insider Profits Down To US$17k
Insiders who bought Gossamer Bio, Inc. (NASDAQ:GOSS) stock lover the last 12 months are probably not as affected by last week’s 17% loss. After taking the recent loss into consideration, the US$138.1k worth of stock they bought is now worth US$155.4k, indicating that their investment yielded a positive return.
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
Check out our latest analysis for Gossamer Bio
Gossamer Bio Insider Transactions Over The Last Year
In the last twelve months, the biggest single purchase by an insider was when COO & CFO Bryan Giraudo bought US$113k worth of shares at a price of US$0.56 per share. We do like to see buying, but this purchase was made at well below the current price of US$0.67. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.
Happily, we note that in the last year insiders paid US$138k for 232.00k shares. But insiders sold 45.88k shares worth US$55k. In total, Gossamer Bio insiders bought more than they sold over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
Gossamer Bio is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Gossamer Bio Insiders Are Selling The Stock
Over the last three months, we've seen significant insider selling at Gossamer Bio. In total, insiders sold US$52k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.
Insider Ownership Of Gossamer Bio
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data suggests Gossamer Bio insiders own 3.0% of the company, worth about US$4.5m. We prefer to see high levels of insider ownership.
So What Does This Data Suggest About Gossamer Bio Insiders?
Insiders sold Gossamer Bio shares recently, but they didn't buy any. In contrast, they appear keener if you look at the last twelve months. Still, insiders don't own a great deal of the stock. So the company doesn't look great on this analysis. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Be aware that Gossamer Bio is showing 5 warning signs in our investment analysis, and 2 of those shouldn't be ignored...
But note: Gossamer Bio may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
